Research summary ·
Drug treatments for fibromyalgia: systematic review and network meta-analysis of randomised trials.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study pooled the results of many earlier drug trials for fibromyalgia. The team searched research databases up to January 2025. They found 151 trials with 32 592 people in total. All people in the trials were adults with fibromyalgia. Trials tested drugs against other drugs, other doses, dummy pills or usual care. Some vitamins and supplements, such as melatonin and vitamin D, were also included. A network method let them compare many drugs at once.
What they found
The proof behind the findings was of low certainty. Sodium oxybate, SNRIs, NRIs and gabapentinoids may raise the chance of feeling clearly better. This was compared with a dummy pill or usual care. Sodium oxybate and SSRIs may ease overall fibromyalgia symptoms. Sleep may improve with tricyclic antidepressants, sodium oxybate or gabapentinoids. No drug had an average effect on pain large enough to matter. The same was true for physical and mental health. Still, with some drugs, more people had a clear drop in pain. These were sodium oxybate, NRIs, SNRIs and cyclobenzaprine. No drug raised the risk of stopping treatment or of serious harms.
What it means for patients
The authors say several drug groups may help people with fibromyalgia. These include sodium oxybate, NRIs, SNRIs, gabapentinoids, tricyclics and SSRIs. The gains were typically small. They were seen only in some outcomes, not in all.
Why it is not certain yet
The authors rated the proof as low certainty. Average effects on pain did not reach a level that clearly matters. The abstract does not say how long people were followed. A review can only be as good as the studies in it.
Source
Drug treatments for fibromyalgia: systematic review and network meta-analysis of randomised trials.
PubMed · PMID 42851751We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Fibromyalgia publications